Annovis Bio, Inc. (ANVS)
1.70
+0.01
(+0.59%)
USD |
NYSE |
Sep 02, 16:00
1.64
-0.06
(-3.53%)
Pre-Market: 06:41
Annovis Bio Price : 1.70 for Sept. 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 02, 2026 | 1.71 | 1.759 | 1.69 | 1.70 | 606825.0 |
| Sep 01, 2026 | 1.73 | 1.73 | 1.67 | 1.69 | 457632.0 |
| Aug 31, 2026 | 1.72 | 1.784 | 1.70 | 1.72 | 425505.0 |
| Aug 28, 2026 | 1.78 | 1.83 | 1.71 | 1.72 | 504513.0 |
| Aug 27, 2026 | 1.76 | 1.81 | 1.76 | 1.81 | 301973.0 |
| Aug 26, 2026 | 1.84 | 1.856 | 1.76 | 1.78 | 235713.0 |
| Aug 25, 2026 | 1.76 | 1.825 | 1.76 | 1.82 | 560283.0 |
| Aug 24, 2026 | 1.83 | 1.83 | 1.74 | 1.75 | 670723.0 |
| Aug 21, 2026 | 1.78 | 1.840 | 1.77 | 1.82 | 618557.0 |
| Aug 20, 2026 | 1.84 | 1.89 | 1.78 | 1.79 | 548818.0 |
| Aug 19, 2026 | 1.90 | 1.90 | 1.79 | 1.85 | 746906.0 |
| Aug 18, 2026 | 1.75 | 1.82 | 1.74 | 1.80 | 449499.0 |
| Aug 17, 2026 | 1.82 | 1.85 | 1.74 | 1.74 | 661966.0 |
| Aug 14, 2026 | 1.83 | 1.90 | 1.80 | 1.85 | 949714.0 |
| Aug 13, 2026 | 1.84 | 1.86 | 1.75 | 1.79 | 712426.0 |
| Aug 12, 2026 | 1.87 | 1.896 | 1.80 | 1.80 | 502308.0 |
| Aug 11, 2026 | 1.91 | 1.91 | 1.855 | 1.89 | 351676.0 |
| Aug 10, 2026 | 1.90 | 1.90 | 1.85 | 1.89 | 321131.0 |
| Aug 07, 2026 | 1.90 | 1.945 | 1.85 | 1.88 | 557276.0 |
| Aug 06, 2026 | 1.91 | 1.91 | 1.81 | 1.86 | 317216.0 |
| Aug 05, 2026 | 1.90 | 1.976 | 1.86 | 1.87 | 1.100M |
| Aug 04, 2026 | 1.75 | 1.905 | 1.72 | 1.87 | 808966.0 |
| Aug 03, 2026 | 1.78 | 1.82 | 1.71 | 1.72 | 460199.0 |
| Jul 31, 2026 | 1.81 | 1.81 | 1.70 | 1.75 | 353013.0 |
| Jul 30, 2026 | 1.72 | 1.79 | 1.715 | 1.77 | 389206.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.93 |
| Alnylam Pharmaceuticals, Inc. | 267.40 |
| Anika Therapeutics, Inc. | 21.55 |
| Savara, Inc. | 5.46 |
| Vericel Corp. | 40.89 |
Price Related Metrics
| Earnings Yield | -105.4% |
| Market Cap | 72.43M |